1. AB0520 Tocilizumab in rheumatoid arthritis – one year interim analysis of the non-interventional ichiban study. (23rd January 2014) Authors: Specker, C.; Kaufmann, J.; Vollmer, M.A.; Kellner, H.; Bohl-Bühler, M.; Aringer, M.; Alberding, A.; Schwenke, H.; Kühne, C.; Lüthke, K.; Tony, H.P.; Zinke, S.; Kapelle, A.; Klopsch, T.; Aries, P.M.; Remstedt, S.; Melzer, A.; Hellmann, P.; Türk, S.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1197 Multiparametric analysis of connective tissue disease specific autoantibodies using a spot immunoassay (SERASPOT®ANA). (12th June 2018) Authors: Conrad, K.; Rejzek, M.; Aringer, M.; Rudolph, S.; Unger, L.; Lüthke, K.; Gräßler, A.; Röber, N. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0565 The Presence of Anti-DFS70 Antibodies Suggests Absence of Connective Tissue Diseases in Patients with Anti-Nuclear Antibodies (ANA). (9th June 2015) Authors: Conrad, K.; Höpner, U.; Röber, N.; Aringer, M.; Rudolph, S.; Gräßler, A.; Lüthke, K.; Unger, L.; Mahler, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0205 Real Life Experience Suggests Differential Effects of Rituximab on Refractory Dermatomyositis and Polymyositis. (23rd January 2014) Authors: Unger, L.; Kampf, S.; Lüthke, K.; Aringer, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗